BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27526298)

  • 41. Expression of the LIM homeobox domain transcription factor ISL1 (Islet-1) is frequent in rhabdomyosarcoma but very limited in other soft tissue sarcoma types.
    Erlenbach-Wünsch K; Haller F; Taubert H; Würl P; Hartmann A; Agaimy A
    Pathology; 2014 Jun; 46(4):289-95. PubMed ID: 24751901
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparison of the transcription of the fetal type acetylcholine receptor and myogenin in rhabdomyosarcoma].
    Gattenlöhner S; Müller-Hermelink HK; Marx A
    Verh Dtsch Ges Pathol; 1998; 82():195-201. PubMed ID: 10095433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity.
    Langdon CG; Gadek KE; Garcia MR; Evans MK; Reed KB; Bush M; Hanna JA; Drummond CJ; Maguire MC; Leavey PJ; Finkelstein D; Jin H; Schreiner PA; Rehg JE; Hatley ME
    Nat Commun; 2021 Sep; 12(1):5520. PubMed ID: 34535684
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group.
    Sorensen PH; Lynch JC; Qualman SJ; Tirabosco R; Lim JF; Maurer HM; Bridge JA; Crist WM; Triche TJ; Barr FG
    J Clin Oncol; 2002 Jun; 20(11):2672-9. PubMed ID: 12039929
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Sclerosing rhabdomyosarcoma: a clinicopathologic study of four cases with review of literature].
    Zhu L; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):587-91. PubMed ID: 18070445
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Expression of c-Myb Correlates with the Levels of Rhabdomyosarcoma-specific Marker Myogenin.
    Kaspar P; Zikova M; Bartunek P; Sterba J; Strnad H; Kren L; Sedlacek R
    Sci Rep; 2015 Oct; 5():15090. PubMed ID: 26462877
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new marker for rhabdomyosarcoma. Insulin-like growth factor II.
    Yun K
    Lab Invest; 1992 Nov; 67(5):653-64. PubMed ID: 1434543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Update on Myogenic Sarcomas.
    Agaram NP
    Surg Pathol Clin; 2019 Mar; 12(1):51-62. PubMed ID: 30709448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass.
    Dias P; Chen B; Dilday B; Palmer H; Hosoi H; Singh S; Wu C; Li X; Thompson J; Parham D; Qualman S; Houghton P
    Am J Pathol; 2000 Feb; 156(2):399-408. PubMed ID: 10666368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pleomorphic rhabdomyosarcoma showing smooth-muscle and fibrohistiocytic differentiation: a single case report.
    Eyden B
    Ultrastruct Pathol; 2010 Feb; 34(1):42-7. PubMed ID: 20070153
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors.
    Carpentieri DF; Nichols K; Chou PM; Matthews M; Pawel B; Huff D
    Mod Pathol; 2002 Oct; 15(10):1080-6. PubMed ID: 12379755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of muscle-specific actins and myosin in light microscopically undifferentiated small and dark cell malignancies of soft tissues.
    Seidal T; Angervall L; Kindblom LG
    APMIS; 1990 Dec; 98(12):1105-12. PubMed ID: 2282206
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sox10--a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors.
    Miettinen M; McCue PA; Sarlomo-Rikala M; Biernat W; Czapiewski P; Kopczynski J; Thompson LD; Lasota J; Wang Z; Fetsch JF
    Am J Surg Pathol; 2015 Jun; 39(6):826-35. PubMed ID: 25724000
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of insulin-like growth factor pathway proteins in rhabdomyosarcoma: IGF-2 expression is associated with translocation-negative tumors.
    Makawita S; Ho M; Durbin AD; Thorner PS; Malkin D; Somers GR
    Pediatr Dev Pathol; 2009; 12(2):127-35. PubMed ID: 18788888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunohistochemical Profile of MYC Protein in Pediatric Small Round Blue Cell Tumors.
    Chisholm KM; Krishnan C; Heerema-McKenney A; Natkunam Y
    Pediatr Dev Pathol; 2017 Jun; 20(3):213-223. PubMed ID: 28521631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Embryonal rhabdomyosarcoma: immunohistochemical characterization.
    Geiger S; Czernobilsky B; Marshak G; Geiger B
    Oral Surg Oral Med Oral Pathol; 1985 Nov; 60(5):517-23. PubMed ID: 2414709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sirtuin 1 (SIRT1): a potential immunohistochemical marker and therapeutic target in soft tissue neoplasms with myoid differentiation.
    Dickson BC; Riddle ND; Brooks JS; Pasha TL; Zhang PJ
    Hum Pathol; 2013 Jun; 44(6):1125-30. PubMed ID: 23332867
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues.
    Kumar S; Perlman E; Harris CA; Raffeld M; Tsokos M
    Mod Pathol; 2000 Sep; 13(9):988-93. PubMed ID: 11007039
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunohistochemistry of MyoD1 in adult pleomorphic soft tissue sarcomas.
    Wesche WA; Fletcher CD; Dias P; Houghton PJ; Parham DM
    Am J Surg Pathol; 1995 Mar; 19(3):261-9. PubMed ID: 7872424
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors.
    Wehrli BM; Huang W; De Crombrugghe B; Ayala AG; Czerniak B
    Hum Pathol; 2003 Mar; 34(3):263-9. PubMed ID: 12673561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.